A former Airedale doctor has released her debut novel, and will donate 20 per cent of her first-year royalties to charity.

近年来，晚期肝细胞癌（aHCC）的治疗取得了显著进展，尤其是一线治疗方案的不断优化为患者带来了新的希望。在近日举行的2024年欧洲肿瘤内科学会（ESMO）年会上，有多项aHCC相关临床研究成果亮相，这些研究均展示了免疫联合疗法在提高晚期肝癌患者生存率和 ...

上海 2024年9月19日 /美通社/ -- 2024年9月16日，和誉医药 依帕戈替尼研究成果在 2024 ESMO大会上荣获"最佳壁报奖" 。该奖项授予题为"依帕戈替尼 ...

The award was received for the presentation titled "Updated Safety and Efficacy of Irpagratinib (ABSK011) in advanced hepatocellular carcinoma (aHCC) with FGF19 overexpression from a Phase 1 study".

One area where Focus V and penpulimab seem to hold an edge over Elevar’s combination is in their safety profile, with fewer ...

2024年9月13-17日，2024年欧洲肿瘤内科学会（ESMO）年会于西班牙巴塞罗那正式召开。作为肿瘤领域最具权威的年度盛会之一，本届年会再次云集全球肿瘤大咖、汇聚领域最新进展。 在当地时间9月13日的上消化道肿瘤优选论文专场中，由中国药科大学附属南京天印山 ...

The APOLLO trial results were received well at ESMO given the previous failure of the LEAP-002 trial with Keytruda/lenvatinib ...

Hepatocellular carcinoma is a type of adjuvant liver cancer. Credit: David A Litman via shutterstock.com. Advanced hepatocellular carcinoma (aHCC) has a dire prognostic outlook, with an 18.4% ...

近日，齐鲁制药在2024年欧洲肿瘤内科学会（ESMO）年会以优选口头报告的形式，公布了旗下双功能组合抗体QL1706一线治疗晚期 ...